RALEIGH, N.C., March 31 /PRNewswire/ -- CLOSURE Medical Corporation
(Nasdaq: CLSR), a medical tissue cohesive products company, today announced
that J. Blount Swain has resigned as the company's Chief Financial Officer.
Mr. Swain had been with Closure since September 1992.
Robert V. Toni, President and CEO said, "Blount has made tremendous
contributions to Closure in the last eight years. He has the opportunity to
join a pre-IPO software company in a senior level position and I wish him the
best in his new venture."
"I have enjoyed my years at Closure Medical and wish the company much
success in the future and now look forward to my transition to the technology
sector," said Swain.
The Company expects to fill the Chief Financial Officer position in the
near future. Until that time Benny Ward, the Company's controller who joined
the company in 1996 prior to the initial public offering, will serve as
Interim CFO and assume all financial management responsibilities. Mr. Swain
will be assisting with the transition during the month of April 2000.
CLOSURE Medical Corporation, headquartered in Raleigh, North Carolina,
develops, manufactures and commercializes medical tissue adhesive products
based on its proprietary cyanoacrylate technology. CLOSURE's nonabsorbable
tissue adhesive products may be used to replace sutures and staples for
certain topical wound closure applications, while its internal tissue adhesive
products, once approved and marketed, could potentially be used for internal
wound closure and management. Currently marketed nonabsorbable tissue
adhesive products include DERMABOND(R)* Topical Skin Adhesive, which is used
to replace sutures and staples for closure of certain lacerations and
incisions, OCTYLDENT(R)* adhesive, which is used as an adjunct in the
treatment of adult periodontal disease; and the NEXABAND(R)* line of topical
adhesives, which are used in veterinary wound closure and management.
* DERMABOND(R) is a trademark of Ethicon, Inc.; SOOTHE-N-SEAL, OCTYLDENT
and NEXABAND are all trademarks of CLOSURE Medical Corporation.
To receive CLOSURE's latest news release and other corporate documents via
fax, at no cost, call 1-800-PRO-INFO, use the Company's symbol CLSR. Or visit
the Financial Relations Board's website at http://www.frbinc.com .
SOURCE CLOSURE Medical Corporation
 back to top
Related links:
http://www.frbinc.com
CONTACT:
Robert V. Toni, President & CEO of CLOSURE
Medical Corporation, 919-876-7800; or General Info, Paul G.
Henning, Analyst Info, Cecelia Heer, Media Info, Deanne Eagle,
212-661-8030, all of The Financial Relations Board for CLOSURE
Medical Corporation
|
